Results 71 to 80 of about 2,162 (197)

Recent advances in pathogenesis, diagnosis, and therapeutic approaches for digestive system involvement in systemic lupus erythematosus

Journal of Digestive Diseases, Volume 25, Issue 7, Page 410-423, July 2024.
This review summarizes the mechanisms, clinical manifestations, and treatment of digestive tract involvement in systemic lupus erythematosus. The mechanisms mainly involve T and B cells, cellular inflammatory factors, and gut microbiota; the pathogenesis causes correspond to clinical manifestations such as abdominal pain, vomiting, and peritonitis. The
Liang Zhou, Shao Zhe Cai, Ling Li Dong
wiley   +1 more source

Pancreatic Panniculitis Without Pancreatopathy: A Rare Complication of Splenic Vein Stenting for Portal Hypertension in Myeloproliferative Syndrome

United European Gastroenterology Journal, Volume 13, Issue 6, Page 1031-1032, July 2025.
Eliza Butnaru, Solène Tran Van, Franck Brazier, Clara Yzet   +3 more
wiley   +1 more source

Real‐world outcomes of vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic syndrome at a tertiary referral centre

British Journal of Haematology, Volume 207, Issue 1, Page 265-269, July 2025.
Lucia Lee, Eric J. Zhao, Robert Schmidt, Alym Abdulla, Gayatri Sreenivasan, Kimberley Ambler, Megan Hiltz, Lynda Foltz, Vicki Chan, Alexandra Legge, Maggie Yuen, Lauren Lee, Paul Yenson, Thomas J. Nevill, Luke Y. C. Chen, Ryan J. Stubbins   +15 more
wiley   +1 more source

Corticosteroid‐triggered acute skeletal muscle loss in lipodystrophy: A case report

Journal of Diabetes Investigation, Volume 15, Issue 6, Page 782-785, June 2024.
Here we report a 28‐year‐old Japanese woman with acquired generalized lipodystrophy, who presented with a rapid reduction in muscle mass by 15% at maximum during the weeks just after corticosteroid treatment was started. She had multiple risk factors for hypercatabolism other than administration of catabolic corticosteroid: lack of metabolic reserves ...
Takayoshi Sasako, Ken Suzuki, Sara Odawara, Hirotsugu Suwanai, Naoko Akuta, Naoto Kubota, Kohjiro Ueki, Takashi Kadowaki, Toshimasa Yamauchi   +8 more
wiley   +1 more source

Near complete remission of an inoperable pancreatic acinar cell carcinoma after BRAF‐/MEK‐inhibitor treatment—A case report and review of the literature

Genes, Chromosomes and Cancer, Volume 63, Issue 2, February 2024.
Abstract Introduction Pancreatic acinar cell carcinomas are rare malignant neoplasms. High‐quality evidence about the best treatment strategy is lacking. We present the case of a 52‐year‐old male with a BRAFV600E‐mutated PACC who experienced a complete remission after chemotherapy with BRAF‐/MEK‐inhibitors. Case The patient presented with upper abdomen
Lennart von Fritsch, Nikolas von Bubnoff, Klaus Weber, Jutta Kirfel, Cleopatra Schreiber, Tobias Keck, Ulrich Wellner   +6 more
wiley   +1 more source

Paniculitis mesentérica como causa de masa abdominal palpable [PDF]

, 2020
Introduction: mesenteric panniculitis is a rare disorder characterized by chronic inflammation of the adipose tissue of the intestinal mesentery, its etiology is unknown.Objective: to describe the clinical and radiological management of a patient with ...
Belaunde Clausell, Antonio, Morales Días, Alicia, Márquez Hernández, Rey Augusto   +2 more
core   +1 more source

Sclerosing Mesenteritis Involving the Small Bowel and Large Bowel Mesentery: A Case Report and Review of the Literature [PDF]

, 2019
Mesenteric Panniculitis/Sclerosing Mesenteritis is an under diagnosed, rare chronic fibrosing inflammatory disease that affects the mesenteric adipose tissue of the small intestine and rarely the mesocolon.
Arshad, MD, Ayesha, Hussain, BS, Aleena
core   +1 more source

Inflammatory Mesenteric Disease and Sarcoidosis-like Reaction in a Patient with Lung Adenocarcinoma Who Received Pembrolizumab: Paraneoplastic Syndrome, Secondary to Checkpoint Inhibitor or Chance Finding?

Current Oncology
Summary: Anti PD1/PD-L1 agents, including pembrolizumab, have revolutionized the oncological treatment of different types of cancer, including non-small cell lung cancer. The most frequent complications associated with this type of treatment are mild and
Luis Posado-Domínguez, María Escribano-Iglesias, Lorena Bellido-Hernández, Johana Gabriela León-Gil, María Asunción Gómez-Muñoz, Felipe Gómez-Caminero López, María Martín-Galache, Sandra M. Inés-Revuelta, Emilio Fonseca-Sánchez   +8 more
doaj   +1 more source

Sclerosing mesenteritis: a benign cause of mesenteric mass lesions

The Pan African Medical Journal, 2017
Sclerosing mesenteritis is a rare disease of the mesentery. Associations with surgery, trauma, autoimmunity and paraneoplastic syndrome have been suggested, but most of the cases remain idiopathic. Diagnosis is often incidental, based upon the finding of
Diogo Carrola Gomes, Luesa Quaresma
doaj   +1 more source

Efficacy of colchicine in the treatment of mesenteric panniculitis in a young patient

The Saudi Journal of Gastroenterology, 2012
Mesenteric panniculitis (MP) is a rare inflammatory and fibrotic disease of the mesentery of unknown etiology. It has various clinical and radiological manifestations, posing a diagnostic challenge for clinicians.
Kostas Fasoulas, Athanasios Beltsis, Taxiarchis Katsinelos, Eleni Dimou, Mary Arvaniti, Anna Charsoula, Victor Gourvas, Stefanos Atmatzidis, Grigoris Chatzimavroudis, Panagiotis Katsinelos   +9 more
doaj   +1 more source